 14. Impairment of gastrointestinal function or gastrointestinal disease that may significantly alter the absorption of study medication e.g., ulcerative disease, uncontrolled nausea, vomiting, diarrhea, malabsorption syndrome or small bowel resection associated with malabsorption 